190 related articles for article (PubMed ID: 35887068)
1. Inhibition of eIF6 Activity Reduces Hepatocellular Carcinoma Growth: An In Vivo and In Vitro Study.
Scagliola A; Miluzio A; Mori G; Ricciardi S; Oliveto S; Manfrini N; Biffo S
Int J Mol Sci; 2022 Jul; 23(14):. PubMed ID: 35887068
[TBL] [Abstract][Full Text] [Related]
2. Targeting of eIF6-driven translation induces a metabolic rewiring that reduces NAFLD and the consequent evolution to hepatocellular carcinoma.
Scagliola A; Miluzio A; Ventura G; Oliveto S; Cordiglieri C; Manfrini N; Cirino D; Ricciardi S; Valenti L; Baselli G; D'Ambrosio R; Maggioni M; Brina D; Bresciani A; Biffo S
Nat Commun; 2021 Aug; 12(1):4878. PubMed ID: 34385447
[TBL] [Abstract][Full Text] [Related]
3. Discovery and Preliminary Characterization of Translational Modulators that Impair the Binding of eIF6 to 60S Ribosomal Subunits.
Pesce E; Miluzio A; Turcano L; Minici C; Cirino D; Calamita P; Manfrini N; Oliveto S; Ricciardi S; Grifantini R; Degano M; Bresciani A; Biffo S
Cells; 2020 Jan; 9(1):. PubMed ID: 31936702
[TBL] [Abstract][Full Text] [Related]
4. Molecular Mechanisms: Connections between Nonalcoholic Fatty Liver Disease, Steatohepatitis and Hepatocellular Carcinoma.
Kanda T; Goto T; Hirotsu Y; Masuzaki R; Moriyama M; Omata M
Int J Mol Sci; 2020 Feb; 21(4):. PubMed ID: 32102237
[TBL] [Abstract][Full Text] [Related]
5. Translational Control of Metabolism and Cell Cycle Progression in Hepatocellular Carcinoma.
Scagliola A; Miluzio A; Biffo S
Int J Mol Sci; 2023 Mar; 24(5):. PubMed ID: 36902316
[TBL] [Abstract][Full Text] [Related]
6. Hepatocellular carcinoma in the context of non-alcoholic steatohepatitis (NASH): recent advances in the pathogenic mechanisms.
Lequoy M; Gigante E; Couty JP; Desbois-Mouthon C
Horm Mol Biol Clin Investig; 2020 Feb; 41(1):. PubMed ID: 32112699
[TBL] [Abstract][Full Text] [Related]
7. eIF6 promotes the malignant progression of human hepatocellular carcinoma via the mTOR signaling pathway.
Sun L; Liu S; Wang X; Zheng X; Chen Y; Shen H
J Transl Med; 2021 May; 19(1):216. PubMed ID: 34016142
[TBL] [Abstract][Full Text] [Related]
8. Long noncoding RNA PICSAR/miR-588/EIF6 axis regulates tumorigenesis of hepatocellular carcinoma by activating PI3K/AKT/mTOR signaling pathway.
Liu Z; Mo H; Sun L; Wang L; Chen T; Yao B; Liu R; Niu Y; Tu K; Xu Q; Yang N
Cancer Sci; 2020 Nov; 111(11):4118-4128. PubMed ID: 32860321
[TBL] [Abstract][Full Text] [Related]
9. Eukaryotic initiation factor 6 is rate-limiting in translation, growth and transformation.
Gandin V; Miluzio A; Barbieri AM; Beugnet A; Kiyokawa H; Marchisio PC; Biffo S
Nature; 2008 Oct; 455(7213):684-8. PubMed ID: 18784653
[TBL] [Abstract][Full Text] [Related]
10. Elevated levels of circulating ITIH4 are associated with hepatocellular carcinoma with nonalcoholic fatty liver disease: from pig model to human study.
Nakamura N; Hatano E; Iguchi K; Sato M; Kawaguchi H; Ohtsu I; Sakurai T; Aizawa N; Iijima H; Nishiguchi S; Tomono T; Okuda Y; Wada S; Seo S; Taura K; Uemoto S; Ikegawa M
BMC Cancer; 2019 Jun; 19(1):621. PubMed ID: 31238892
[TBL] [Abstract][Full Text] [Related]
11. Molecular Pathogenesis of Nonalcoholic Steatohepatitis- (NASH-) Related Hepatocellular Carcinoma.
Kutlu O; Kaleli HN; Ozer E
Can J Gastroenterol Hepatol; 2018; 2018():8543763. PubMed ID: 30228976
[TBL] [Abstract][Full Text] [Related]
12. eIF6 anti-association activity is required for ribosome biogenesis, translational control and tumor progression.
Brina D; Miluzio A; Ricciardi S; Biffo S
Biochim Biophys Acta; 2015 Jul; 1849(7):830-5. PubMed ID: 25252159
[TBL] [Abstract][Full Text] [Related]
13. TUBB4B is a novel therapeutic target in non-alcoholic fatty liver disease-associated hepatocellular carcinoma.
Yang Z; Gao S; Wong CC; Liu W; Chen H; Shang H; Wu ZY; Xu L; Zhang X; Wong N; Kuang M; Yu J
J Pathol; 2023 May; 260(1):71-83. PubMed ID: 36787097
[TBL] [Abstract][Full Text] [Related]
14. Notch activity characterizes a common hepatocellular carcinoma subtype with unique molecular and clinicopathologic features.
Zhu C; Ho YJ; Salomao MA; Dapito DH; Bartolome A; Schwabe RF; Lee JS; Lowe SW; Pajvani UB
J Hepatol; 2021 Mar; 74(3):613-626. PubMed ID: 33038431
[TBL] [Abstract][Full Text] [Related]
15. High levels of eukaryotic Initiation Factor 6 (eIF6) are required for immune system homeostasis and for steering the glycolytic flux of TCR-stimulated CD4
Manfrini N; Ricciardi S; Miluzio A; Fedeli M; Scagliola A; Gallo S; Brina D; Adler T; Busch DH; Gailus-Durner V; Fuchs H; Hrabě de Angelis M; Biffo S
Dev Comp Immunol; 2017 Dec; 77():69-76. PubMed ID: 28743432
[TBL] [Abstract][Full Text] [Related]
16. MicroRNA expression analysis in high fat diet-induced NAFLD-NASH-HCC progression: study on C57BL/6J mice.
Tessitore A; Cicciarelli G; Del Vecchio F; Gaggiano A; Verzella D; Fischietti M; Mastroiaco V; Vetuschi A; Sferra R; Barnabei R; Capece D; Zazzeroni F; Alesse E
BMC Cancer; 2016 Jan; 16():3. PubMed ID: 26728044
[TBL] [Abstract][Full Text] [Related]
17. Targeted Inhibition of LPL/FABP4/CPT1 fatty acid metabolic axis can effectively prevent the progression of nonalcoholic steatohepatitis to liver cancer.
Yang H; Deng Q; Ni T; Liu Y; Lu L; Dai H; Wang H; Yang W
Int J Biol Sci; 2021; 17(15):4207-4222. PubMed ID: 34803493
[No Abstract] [Full Text] [Related]
18. Hepatocellular carcinoma and non-alcoholic steatohepatitis: The state of play.
Charrez B; Qiao L; Hebbard L
World J Gastroenterol; 2016 Feb; 22(8):2494-502. PubMed ID: 26937137
[TBL] [Abstract][Full Text] [Related]
19. Defects in long-chain 3-hydroxy acyl-CoA dehydrogenase lead to hepatocellular carcinoma: A novel etiology of hepatocellular carcinoma.
Khare T; Khare S; Angdisen JJ; Zhang Q; Stuckel A; Mooney BP; Ridenhour SE; Gitan RS; Hammoud GM; Ibdah JA
Int J Cancer; 2020 Sep; 147(5):1461-1473. PubMed ID: 32115688
[TBL] [Abstract][Full Text] [Related]
20. A Regulatory Role of Apoptosis Antagonizing Transcription Factor in the Pathogenesis of Nonalcoholic Fatty Liver Disease and Hepatocellular Carcinoma.
Kumar DP; Santhekadur PK; Seneshaw M; Mirshahi F; Uram-Tuculescu C; Sanyal AJ
Hepatology; 2019 Apr; 69(4):1520-1534. PubMed ID: 30394550
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
